These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 12161479)

  • 1. Arterial embolization: a novel approach to thyroid ablative therapy for Graves' disease.
    Xiao H; Zhuang W; Wang S; Yu B; Chen G; Zhou M; Wong NC
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3583-9. PubMed ID: 12161479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroid arterial embolization to treat Graves' disease.
    Zhao W; Gao BL; Yang HY; Li H; Song DP; Xiang ST; Shen J
    Acta Radiol; 2007 Mar; 48(2):186-92. PubMed ID: 17354140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Graves' disease treated with thyroid arterial embolization.
    Zhao W; Gao BL; Tian M; Yi GF; Yang HY; Shen LJ; Li H; Shen J
    Clin Invest Med; 2009 Apr; 32(2):E158-65. PubMed ID: 19331805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioactive iodine ablation therapy: a viable option in the management of Graves' disease in Nigeria.
    Adedapo KS; Fadiji IO; Orunmuyi AT; Onimode Y; Osifo BO
    Afr J Med Med Sci; 2012 Dec; 41 Suppl():193-6. PubMed ID: 23678656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High dose of (131)I therapy for the treatment of hyperthyroidism caused by Graves' disease.
    Alexander EK; Larsen PR
    J Clin Endocrinol Metab; 2002 Mar; 87(3):1073-7. PubMed ID: 11889166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partial thyroid arterial embolization for the treatment of hyperthyroidism.
    Brzozowski K; Piasecki P; Zięcina P; Frankowska E; Jaroszuk A; Kamiński G; Bogusławska-Walecka R
    Eur J Radiol; 2012 Jun; 81(6):1192-6. PubMed ID: 21501939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment outcome of Graves' disease in Thai children.
    Somnuke PH; Pusuwan P; Likitmaskul S; Santiprabhob J; Sawathiparnich P
    J Med Assoc Thai; 2007 Sep; 90(9):1815-20. PubMed ID: 17957924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of chronic iodine administration on thyroid status in euthyroid subjects previously treated with antithyroid drugs for Graves' hyperthyroidism.
    Roti E; Gardini E; Minelli R; Bianconi L; Salvi M; Gavaruzzi G; Braverman LE
    J Clin Endocrinol Metab; 1993 Apr; 76(4):928-32. PubMed ID: 7682562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The calcium-phosphate balance, modulation of thyroid autoimmune processes and other adverse effects connected with thyroid arterial embolization.
    Kaminski G; Jaroszuk A; Zybek A; Brzozowski K; Piasecki P; Ziecina P; Ruchala M
    Endocrine; 2014 Jun; 46(2):292-9. PubMed ID: 24146411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioactive iodine therapy in Graves' hyperthyroidism: a prospective study from a tertiary referral centre in north India.
    Sankar R; Sekhri T; Sripathy G; Walia RP; Jain SK
    J Assoc Physicians India; 2005 Jul; 53():603-6. PubMed ID: 16190128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of Graves' disease: effects of the administration of L-thyroxine associated with methimazole as a single daily dose.
    Perozim LM; Lima N; Knobel M; Cavaliere H; Medeiros-Neto G
    Eur J Med; 1993 Feb; 2(2):70-4. PubMed ID: 8258020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiogenic study in Graves' disease treated with thyroid arterial embolization.
    Zhao W; Gao BL; Liu ZY; Yi GF; Shen LJ; Yang HY; Li H; Song DP; Jiang YN; Hu JH; Luo G
    Clin Invest Med; 2009 Oct; 32(5):E335-44. PubMed ID: 19796574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained control of Graves' hyperthyroidism during long-term low-dose antithyroid drug therapy of patients with severe Graves' orbitopathy.
    Laurberg P; Berman DC; Andersen S; Bülow Pedersen I
    Thyroid; 2011 Sep; 21(9):951-6. PubMed ID: 21834677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A predictive mathematical model for the calculation of the final mass of Graves' disease thyroids treated with 131I.
    Traino AC; Di Martino F; Grosso M; Monzani F; Dardano A; Caraccio N; Mariani G; Lazzeri M
    Phys Med Biol; 2005 May; 50(9):2181-91. PubMed ID: 15843745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Arterial thyroid embolization in thyroid diseases].
    Jaroszuk A; Kamiński G
    Pol Merkur Lekarski; 2011 Nov; 31(185):284-7. PubMed ID: 22299530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term carbimazole intake does not affect success rate of radioactive 131Iodine in treatment of Graves' hyperthyroidism.
    El Refaei SM; Shawkat W
    Nucl Med Commun; 2008 Jul; 29(7):642-8. PubMed ID: 18528187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid response, especially to thyrotropin-binding inhibitory immunoglobulins, in euthyroid relatives of patients with Graves' disease: a clinical follow-up.
    Tamai H; Kasagi K; Morita T; Hidaka A; Kuma K; Konishi J; Kumagai LF; Nagataki S
    J Clin Endocrinol Metab; 1990 Jul; 71(1):210-5. PubMed ID: 1973421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroidal triiodothyronine and thyroxine in Graves' disease: correlation with presurgical treatment, thyroid status, and iodine content.
    Larsen PR
    J Clin Endocrinol Metab; 1975 Dec; 41(06):1098-104. PubMed ID: 54364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radioactive iodine in the treatment of Graves' disease.
    Al-Kaabi JM; Hussein SS; Bukheit CS; Woodhouse NJ; Elshafie OT; Bererhi H
    Saudi Med J; 2002 Sep; 23(9):1049-53. PubMed ID: 12370710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One-year follow-up of Graves' disease treatment by four different protocols of radioiodine administration.
    Calegaro JU; De Freitas Gomes E; Bae SH; Ulyssea R; Casulari LA
    Panminerva Med; 2000 Dec; 42(4):241-5. PubMed ID: 11294085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.